Reports for SANOFI-AVENTIS CANADA INC
Company Name SANOFI-AVENTIS CANADA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
281 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 260 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
22 (6%) |
|
Overdue reports |
9 (75%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2022-03-16 | 2022-07-12 | 156783 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2023-07-19 | 2023-07-21 | 199221 |
| RENAGEL | 800MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-12 | 255211 |
| RENVELA | 800MG | TABLET | Resolved | 2019-01-04 | 2019-01-10 | 71284 |
| RENVELA | 800MG | TABLET | Resolved | 2024-02-16 | 2024-05-15 | 219863 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Resolved | 2024-07-26 | 2025-04-03 | 233720 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Resolved | 2024-10-22 | 2025-04-03 | 240885 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2019-05-28 | 2019-10-15 | 84937 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2021-02-16 | 2021-05-22 | 134202 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2024-02-23 | 208624 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2018-01-10 | 2018-02-02 | 35644 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79293 |
| RIFADIN | 300MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79314 |
| RILUTEK | 50MG | TABLET | Resolved | 2019-11-14 | 2021-09-29 | 98763 |
| SECTRAL | 100MG | TABLET | Resolved | 2018-05-08 | 2018-07-31 | 48844 |
| SECTRAL | 200MG | TABLET | Resolved | 2018-04-18 | 2018-07-27 | 46276 |
| SOLIQUA | 33MCG 100UNIT | SOLUTION | Resolved | 2022-07-22 | 2022-08-04 | 165375 |
| TALWIN | 50MG | TABLET | Resolved | 2018-08-14 | 2019-04-03 | 58104 |
| THYMOGLOBULIN | 25MG | POWDER FOR SOLUTION | Avoided shortage | 2019-01-28 | 2019-03-22 | 73721 |
| THYROGEN | 0.9MG | POWDER FOR SOLUTION | Resolved | 2022-01-13 | 2022-02-08 | 152688 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 800MG | TABLET | To be discontinued | 2025-03-31 | 2025-03-31 | 253680 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZUACTA | 0.075% | CREAM | Discontinued | 2020-07-30 | 2020-07-30 | 121381 |